دورية أكاديمية
N-Chromosome Royal Jelly, Propolis and Bee Pollen Supplementation Improve the Clinical Conditions of COVID-19 Patients: A Randomized Controlled Trial
| العنوان: | N-Chromosome Royal Jelly, Propolis and Bee Pollen Supplementation Improve the Clinical Conditions of COVID-19 Patients: A Randomized Controlled Trial |
|---|---|
| المؤلفون: | Atefeh Abedini, Shadi Shafaghi, Zahra Ameri Ahmad, Elmira Javanmardi, Fariba Ghorbani, Babak Sharif-Kashani, Farah Naghashzadeh, Masoud Shafaghi, Melina Moshirpour, Sima Noorali, Hoda Hakimian, Mohammad Sadegh Keshmiri, Aylar Fazlzadeh |
| المصدر: | Traditional and Integrative Medicine, Vol 6, Iss 4 (2021) |
| بيانات النشر: | Tehran University of Medical Sciences, 2021. |
| سنة النشر: | 2021 |
| المجموعة: | LCC:Public aspects of medicine |
| مصطلحات موضوعية: | Royal jelly, Bee pollen, Propolis, Hyperinflammation, Corona virus disease 2019 (COVID-19), Public aspects of medicine, RA1-1270 |
| الوصف: | Royal jelly, propolis, and bee pollen are used for different purposes all around the world according to their anti-inflammatory, antioxidant, and antimicrobial activities. Given that Coronavirus 2019 (COVID-19) is a viral condition accompanied by a dysregulated inflammatory response in the body, we intend to evaluate the effects of natural supplementations on the disease course. A randomized, open-label, controlled trial was conducted among 50 definitive cases of COVID-19. These patients were randomly assigned into control and intervention groups. Royal Jelly, propolis, and bee pollen were prescribed to patients in the intervention group (n = 24) in addition to conventional treatment; while the control group only received the standard treatment (n = 26). At the end of the study, functional class improved in both groups, but this change was more pronounced in the intervention group (p < 0.05). Moreover, total symptoms duration and the time to return to work were significantly reduced in the intervention group (p < 0.05). Although royal jelly, propolis, and bee pollen are not definitive treatments in COVID-19 patients, they can be used as an adjuvant treatment to limit disease symptoms and virus propagation. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2476-5104 2476-5112 |
| العلاقة: | https://jtim.tums.ac.ir/index.php/jtim/article/view/408Test; https://doaj.org/toc/2476-5104Test; https://doaj.org/toc/2476-5112Test |
| DOI: | 10.18502/tim.v6i4.8269 |
| الوصول الحر: | https://doaj.org/article/dec42ba2f3bf4ca194e293ff35afccdfTest |
| رقم الانضمام: | edsdoj.42ba2f3bf4ca194e293ff35afccdf |
| قاعدة البيانات: | Directory of Open Access Journals |
| تدمد: | 24765104 24765112 |
|---|---|
| DOI: | 10.18502/tim.v6i4.8269 |